New Research: Contribution of SARS-CoV-2 infection preceding COVID-19 mRNA vaccination to generation of cellular and humoral immune responses in children: Primary COVID-19 vaccination for children, 5-17 years of age, was offered in the… https://t.co/DBqQxv
33,294 followers
927 followers
RT @AAPSonline: Children, 5-17 years of age: A second vaccine dose did not further boost antibody levels in those who previously experience…
94 followers
RT @AAPSonline: Children, 5-17 years of age: A second vaccine dose did not further boost antibody levels in those who previously experience…
45,042 followers
Children, 5-17 years of age: A second vaccine dose did not further boost antibody levels in those who previously experienced an infection. https://t.co/SaTlrNYawE